Login / Signup

Return-to-baseline multiple imputation for missing values in clinical trials.

Yongming QuBiyue Dai
Published in: Pharmaceutical statistics (2022)
Return-to-baseline is an important method to impute missing values or unobserved potential outcomes when certain hypothetical strategies are used to handle intercurrent events in clinical trials. Current return-to-baseline approaches seen in literature and in practice inflate the variability of the "complete" dataset after imputation and lead to biased mean estimators when the probability of missingness depends on the observed baseline and/or postbaseline intermediate outcomes. In this article, we first provide a set of criteria a return-to-baseline imputation method should satisfy. Under this framework, we propose a novel return-to-baseline imputation method. Simulations show the completed data after the new imputation approach have the proper distribution, and the estimators based on the new imputation method outperform the traditional method in terms of both bias and variance, when missingness depends on the observed values. The new method can be implemented easily with the existing multiple imputation procedures in commonly used statistical packages.
Keyphrases
  • clinical trial
  • healthcare
  • systematic review
  • primary care
  • metabolic syndrome
  • risk assessment
  • adipose tissue
  • weight loss
  • skeletal muscle
  • molecular dynamics
  • insulin resistance
  • study protocol
  • glycemic control